Pharvaris (PHVS) Other Non-Current Assets (2020 - 2023)
Pharvaris' (PHVS) quarterly Other Non-Current Assets came in at $667959.6 in Q4 2023, up 12.38% YoY from $594384.9 in Q4 2022, and down 35.33% on a QoQ basis from $1.0 million in Q2 2023.
Analysis
Pharvaris (PHVS) Other Non-Current Assets (2020 - 2023) Analysis & Trends
Pharvaris (PHVS) has 4 years of Other Non-Current Assets data on file, last reported at $667959.6 in Q4 2023.
- Quarterly Other Non-Current Assets rose 12.38% year-over-year to $667959.6 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $667959.6 (up 12.38% YoY) and the FY2023 annual result came in at $671546.5, up 9.37% from the prior year.
- Other Non-Current Assets slipped to $667959.6 in Q4 2023, from $1.0 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.4 million in Q4 2020 to a low of $6519.5 in Q4 2021.
- A 4-year average of $749496.7 and a median of $667959.6 in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2021 — Other Non-Current Assets sank 99.55% — and 2022, when it jumped 9017.05%.
- Tracing PHVS's Other Non-Current Assets over 4 years: stood at $1.4 million in 2020, then slumped by 99.55% to $6519.5 in 2021, then jumped by 9017.05% to $594384.9 in 2022, then increased by 12.38% to $667959.6 in 2023.
- The last three Other Non-Current Assets figures came in at $667959.6 (Q4 2023), $1.0 million (Q2 2023), and $594384.9 (Q4 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 618.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 42.45 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 109.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 65.13 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 62.96 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Pharvaris | 2.10 Bn | 1.73 Bn | 85,072.10 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 667,959.63 |
| Jun 30, 2023 | 1.03 Mn |
| Dec 31, 2022 | 594,384.89 |
| Dec 31, 2021 | 6,519.49 |
| Dec 31, 2020 | 1.45 Mn |